At a glance
- Originator Endorecherche
- Class Antineoplastics
- Mechanism of Action Estrogen receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Breast cancer
Most Recent Events
- 17 Aug 2001 Discontinued-Preclinical for Breast cancer in Canada (Unknown route)
- 31 Oct 1997 No-Development-Reported for Breast cancer in Canada (Unknown route)
- 03 Jul 1996 New profile